Health Care
IB Launching an Expanded Access Program for GaM | 10-Jan-2024 | 07:00 | RNS |
Imaging Biometrics granted FDA â€!... | 19-Dec-2023 | 14:29 | RNS |
IQ-AI Announces Positive Interim Phase 1 Results | 05-Dec-2023 | 10:58 | RNS |
Holding(s) in Company | 20-Nov-2023 | 13:42 | RNS |
Director Dealing and Conversion of CLNs | 09-Nov-2023 | 11:38 | RNS |
Application for Pediatric Rare Disease Designation | 08-Nov-2023 | 10:59 | RNS |
Holding(s) in Company | 06-Nov-2023 | 13:02 | RNS |
Update Regarding Imaging Biometrics LLC | 18-Oct-2023 | 14:29 | RNS |
IB Letter to Shareholders | 13-Oct-2023 | 08:55 | RNS |
Orphan Drug Status to GaM and Total Voting Rights | 09-Oct-2023 | 07:00 | RNS |
Holding(s) in Company | 03-Oct-2023 | 11:30 | RNS |
IQ-AI shares cease trading on the OTCQB | 19-Sep-2023 | 14:32 | RNS |
Reduced Gadolinium Approach Validated' | 08-Sep-2023 | 07:00 | RNS |
Update on Collaboration Agreement with Mayo Clinic | 18-Aug-2023 | 12:06 | RNS |
IB & GE HealthCare Enter into Commercial Agreement | 18-Aug-2023 | 11:20 | RNS |
Currency | UK Pounds |
Share Price | 1.34p |
Change Today | -0.060p |
% Change | -4.29 % |
52 Week High | 5.70 |
52 Week Low | 1.30 |
Volume | 22,293 |
Shares Issued | 221.71m |
Market Cap | £2.97m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:00 | 21,213 @ 1.50p |
11:00 | 21,213 @ 1.50p |
09:49 | 514 @ 1.30p |
09:49 | 500 @ 1.50p |
09:49 | 66 @ 1.50p |
You are here: research